Faculty who have authored publication Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion.
Name | Title | Department | Institution |
---|---|---|---|
James P. Thomas MD, PhD | Professor | Medicine | Medical College of Wisconsin |